Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 335

    1.

    Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease.

    Myers TD, Smith JR, Wertheim MS, Egan RA, Shults WT, Rosenbaum JT.

    Br J Ophthalmol. 2004 May;88(5):673-80. Review.PMID: 15090422 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pharmacotherapeutic management of pulmonary sarcoidosis.

    Fazzi P.

    Am J Respir Med. 2003;2(4):311-20. Review.PMID: 14719997 [PubMed - indexed for MEDLINE]Related articles

    3.

    Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.

    Baker KB, Spurrier NJ, Watkins AS, Smith JR, Rosenbaum JT.

    Br J Ophthalmol. 2006 Dec;90(12):1481-5. Epub 2006 Aug 16. Erratum in: Br J Ophthalmol. 2008 Apr;92(4):584. PMID: 16914474 [PubMed - indexed for MEDLINE]Related articles

    4.

    Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review.

    Lin YC, Wang AG, Yen MY.

    Acta Ophthalmol. 2009 Mar;87(2):204-10. Epub 2008 May 27. Review.PMID: 18507726 [PubMed - indexed for MEDLINE]Related articles

    5.

    Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.

    Neumann R, Foster CS.

    Retina. 1995;15(3):201-12.PMID: 7569347 [PubMed - indexed for MEDLINE]Related articles

    6.

    The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease.

    Kim SJ, Yu HG.

    Ocul Immunol Inflamm. 2007 Sep-Oct;15(5):381-7.PMID: 17972222 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.

    Becker MD, Wertheim MS, Smith JR, Rosenbaum JT.

    Ocul Immunol Inflamm. 2005 Jul-Aug;13(4):289-93.PMID: 16159719 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial.

    Galindo-Rodríguez G, Aviña-Zubieta JA, Pizarro S, Díaz de León V, Saucedo N, Fuentes M, Lavalle C.

    Am J Med. 1999 Jan;106(1):65-9.PMID: 10320119 [PubMed - indexed for MEDLINE]Related articles

    9.

    Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

    Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS.

    Ophthalmology. 1996 May;103(5):768-75.PMID: 8637685 [PubMed - indexed for MEDLINE]Related articles

    10.

    Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis.

    Mitre E, Talaat KR, Sperling MR, Nash TE.

    Clin Infect Dis. 2007 Feb 15;44(4):549-53. Epub 2007 Jan 8.PMID: 17243058 [PubMed - indexed for MEDLINE]Related articles

    11.

    Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.

    Kiss S, Ahmed M, Letko E, Foster CS.

    Ophthalmology. 2005 Jun;112(6):1066-71.PMID: 15936442 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)]

    Wakakura M, Ishikawa S, Oono S, Tabuchi A, Kani K, Tazawa Y, Nakao Y, Kiyosawa M, Kawai K, Oohira A, et al.

    Nippon Ganka Gakkai Zasshi. 1995 Jan;99(1):93-7. Japanese. PMID: 7887334 [PubMed - indexed for MEDLINE]Related articles

    13.

    A role for methotrexate in the management of non-infectious orbital inflammatory disease.

    Smith JR, Rosenbaum JT.

    Br J Ophthalmol. 2001 Oct;85(10):1220-4.PMID: 11567968 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Management of optic neuritis.

    Hepler RS.

    Surv Ophthalmol. 1976 Mar-Apr;20(5):350-7.PMID: 178061 [PubMed - indexed for MEDLINE]Related articles

    15.

    Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.

    Abou Zeid N, Bhatti MT.

    Neurologist. 2008 Jul;14(4):207-23. Review. Erratum in: Neurologist. 2009 Jan;15(1):52. Zeid, Nuhad Abou [corrected to Abou Zeid, Nuhad]. PMID: 18617847 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Autoimmune optic neuritis]

    Kerty E, Aanonsen NO, Nyberg-Hansen R.

    Tidsskr Nor Laegeforen. 1992 Jan 30;112(3):335-6. Norwegian. PMID: 1553669 [PubMed - indexed for MEDLINE]Related articles

    17.

    Optic neuritis with concurrent etanercept and isoniazid therapy.

    Noguera-Pons R, Borrás-Blasco J, Romero-Crespo I, Antón-Torres R, Navarro-Ruiz A, González-Ferrandez JA.

    Ann Pharmacother. 2005 Dec;39(12):2131-5. Epub 2005 Nov 1.PMID: 16264061 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Ophthalmologic manifestations of systemic vasculitis: report of six cases and review of the literature]

    Delarbre X, André M, Dalens H, Delèvaux I, Lhoste-Trouilloud A, Tridon A, Schmidt J, Chanet V, Piette JC, Aumaître O.

    Rev Med Interne. 2001 Nov;22(11):1039-48. Review. French. PMID: 11817116 [PubMed - indexed for MEDLINE]Related articles

    19.

    Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis.

    Kaplan-Messas A, Barkana Y, Avni I, Neumann R.

    Ocul Immunol Inflamm. 2003 Jun;11(2):131-9.PMID: 14533032 [PubMed - indexed for MEDLINE]Related articles

    20.

    Autoimmune optic neuropathy: evaluation and treatment.

    Kupersmith MJ, Burde RM, Warren FA, Klingele TG, Frohman LP, Mitnick H.

    J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1381-6. Erratum in: J Neurol Neurosurg Psychiatry 1989 May;52(5):692. PMID: 3266235 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data